Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
100 participants
OBSERVATIONAL
2022-08-20
2025-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ability to Awaken in Nonmonosymptomatic Enuresis
NCT02845648
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
NCT06285006
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
NCT05617664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Desmopressin 120mcg
Patients treated with desmopressin 120 mcg
desmopressin melt form 120 μg
Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.
Desmopressin 240 mcg
Patients treated with desmopressin 240mcg
Desmopressin lyophilisate (Melt)
Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.
Desmopressin 240 mcg + anticholinergic
Patients treated with desmopressin 240mcg + anticholinergic agent
Propiverine tablet
Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
desmopressin melt form 120 μg
Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.
Desmopressin lyophilisate (Melt)
Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.
Propiverine tablet
Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have uroflowmetry test
Exclusion Criteria
* Presence of anatomical or neurological problems
* Patients with missing data
5 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Furkan Adem Canbaz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Furkan Adem Canbaz
Medical doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sancaktepe Sehit Prof dr Ilhan Varank Training and Research Hospital
Istanbul, Kadikoy, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kang BJ, Chung JM, Lee SD. Evaluation of Functional Bladder Capacity in Children with Nocturnal Enuresis According to Type and Treatment Outcome. Res Rep Urol. 2020 Sep 15;12:383-389. doi: 10.2147/RRU.S267417. eCollection 2020.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ivstrh - UF PMNE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.